FAQ

NSC-109,724

Known as: NSC 109,724, NSC109724, NSC109,724 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1972-1989
02419721989

Related topics

Related topics

1 relation

Broader (1)

Ifosfamide

Related mentions per year

Related mentions per year

1961-2018
1960198020002020
NSC-109,724
Ifosfamide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study).
A phase II trial of ifosfamide (isophosphamide, NSC 109724) and mesna (2-mercaptoethane sodium sulfonate, NSC 113891) in women… (More)
Is this relevant?
1976
1976
Studies on the metabolism of isopnosphamide (NSC-109724) in man.
A method is described for the quantitative determination of cyclophosphamide, isophosphamide, and trophosphamide and their stable… (More)
Is this relevant?
1976
1976
Studies on the human pharmacokinetics of isophosphamide (NSC-109724).
The pharmacokinetics of isophosphamide (IP) in man has been studied using 14C-labeled drug and differential extraction of… (More)
Is this relevant?
1976
1976
Phase I clinical trial of a 3-day divided dose schedule of ifosfamide (NSC 109724).
 
Is this relevant?
1976
1976
Studies on the clinical pharmacology and toxicology of isophosphamide (NSC-109724).
 
Is this relevant?
1975
1975
Phase I clinical trial of isophosphamide (NSC-109724).
An initial clinical phase I trial of isophosphamide has been carried out at dose levels of 200-10,000 mg/m2 of body surface area… (More)
Is this relevant?
1974
1974
Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer.
 
Is this relevant?
1974
1974
Renal dysfunction after treatment with isophosphamide (NSC-109724).
 
Is this relevant?
1973
1973
Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia.
 
Is this relevant?
1972
1972
In vitro activation of isophosphamide (NSC-109724), a new oxazaphosphorine, by rat liver microsomes.
 
Is this relevant?